Correlation Between Salarius Pharmaceuticals and Corvus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salarius Pharmaceuticals and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Corvus Pharmaceuticals.

Diversification Opportunities for Salarius Pharmaceuticals and Corvus Pharmaceuticals

-0.07

Correlation Coefficient

Salarius Pharmaceuticals  Corvus Pharmaceuticals

Good diversification

The 3 months correlation between Salarius and Corvus is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Corvus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Salarius Pharmaceuticals and Corvus Pharmaceuticals

Given the investment horizon of 90 days Salarius Pharmaceuticals is expected to generate 1.09 times less return on investment than Corvus Pharmaceuticals. In addition to that, Salarius Pharmaceuticals is 1.94 times more volatile than Corvus Pharmaceuticals. It trades about 0.03 of its total potential returns per unit of risk. Corvus Pharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest  357.00  in Corvus Pharmaceuticals on May 5, 2025 and sell it today you would earn a total of  53.00  from holding Corvus Pharmaceuticals or generate 14.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Salarius Pharmaceuticals  vs.  Corvus Pharmaceuticals

Salarius Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Salarius Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Salarius Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Corvus Pharmaceuticals

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Salarius Pharmaceuticals and Corvus Pharmaceuticals

The main advantage of trading using opposite Salarius Pharmaceuticals and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.

The idea behind Salarius Pharmaceuticals and Corvus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.